Blog

DEEP RESEARCH · INBODY EARNINGS REVIEW

[InBody] Review of Q4 2024 Preliminary Results

A short investment memo on preliminary results that explain headcount growth and a quarterly-dividend item in the shareholder-meeting agenda

Date: 2025-02-22 · Q4 preliminary results and shareholder-meeting agenda check · Naver Blog

Investment decisions are your own responsibility. This material is research and is not a buy or sell recommendation.

0. Bottom line first

The results seem to show why headcount increased. The shareholder-meeting agenda also includes quarterly dividends, so I need to check whether shareholder returns may change.

InBody fourth-quarter preliminary earnings review image

1. Original report

Official fact: The source provides the original report link posted by analyst Kim Chung-hyun: Mirae Asset Securities original report.

Interpretation: I view this as evidence to check whether InBody's investment in people is starting to show in results. The key question is whether “the most efficient investment is investment in people” becomes visible in the numbers.

InBody checkpointsPreliminary results and shareholder-return agenda together
HeadcountReason for higher costs
Q4 resultsInvestment effect
ReportMirae Asset source
AGMQuarterly dividend item
The memo checks whether investment in people connects to results and shareholder returns

2. Shareholder-meeting notice and quarterly dividends

The source preserves an image of the shareholder-meeting notice and emphasizes that quarterly dividends are on the agenda. The author also notes an intention to attend and check directly.

InBody shareholders meeting notice image

3. Next items to verify

  • Which business units and regions drove the headcount increase.
  • How revenue growth, operating margin, and SG&A ratio move after the hiring investment.
  • Whether the quarterly-dividend agenda leads to a real change in bylaws or shareholder-return policy.
  • The gap between the report's estimates and the company's preliminary results.